-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
BASF recently announced that plans to increase its diphenylmethane diisocyanate (MDI) capacity at its integrated site in Geismar, Louisiana, are on schedule
.
Over time, BASF plans to double its production capacity from 300,000 tonnes/year to about 600,000 tonnes/year
.
Dr.
Ramkumar Dhruva, President of BASF's Monomer Division, said: "This investment in the very attractive North American MDI market strengthens our position as a leading MDI supplier in North America and globally
.
"
Stefan Doerr, Senior Vice President of BASF Monomers North America, said: “The Geismar plant is ideal for this investment due to the existing infrastructure, competitive raw materials and continued strong business support from state and local governments
.
With this complex, BASF will continue to support the growth of our North American MDI customers
.
"
The first phase involved the construction of a new MDI synthesis unit, which has been in operation since October last year
.
The recently launched second phase expands several existing upstream units and increases total MDI production at the Geismar complex by about a third
.
Works on the final phase of the MDI expansion are progressing on schedule
.
The final phase of the expansion project, which includes several new upstream units, is expected to be completed by the middle of this century, with a final total MDI capacity of about 600,000 tonnes/year
.
